Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Recombinant Protein Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Recombinant DNA
Recombinant RNA
Application:
Pharmaceutical Industry
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Recombinant Protein Drugs Industry Overview
-
1.1.1 Recombinant Protein Drugs Market Scope and Market Segments
-
1.1.2 Recombinant Protein Drugs Industry Characteristics
-
1.1.3 Global and China Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Recombinant Protein Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Recombinant Protein Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Recombinant DNA
-
1.2.2 Recombinant RNA
-
1.3 Global Recombinant Protein Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Pharmaceutical Industry
-
1.3.2 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Recombinant Protein Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Recombinant Protein Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Recombinant Protein Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Recombinant Protein Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Recombinant Protein Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Recombinant Protein Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Recombinant Protein Drugs Industry PEST Analysis
-
2.3 Recombinant Protein Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Recombinant Protein Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Recombinant Protein Drugs Industry
Chapter 3 Global and China Recombinant Protein Drugs Market, by Manufacturer
-
3.1 Global and China Recombinant Protein Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Recombinant Protein Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Recombinant Protein Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Recombinant Protein Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Recombinant Protein Drugs Market Top 3 Players
Chapter 4 Global and China Recombinant Protein Drugs Market, by Type (2017-2028)
-
4.1 Recombinant Protein Drugs Market Trend, by Type
-
4.2 Global Recombinant Protein Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Recombinant Protein Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Recombinant Protein Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Recombinant Protein Drugs Price Trend, by Type (2017-2028)
-
4.3 China Recombinant Protein Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Recombinant Protein Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Recombinant Protein Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Recombinant Protein Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Recombinant Protein Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Recombinant Protein Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Recombinant Protein Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Recombinant Protein Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Recombinant Protein Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Recombinant Protein Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Recombinant Protein Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Recombinant Protein Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Recombinant Protein Drugs Market Analysis
-
7.1 North America Recombinant Protein Drugs Market, by Type
-
7.2 North America Recombinant Protein Drugs Market, by Application
-
7.3 North America Recombinant Protein Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Recombinant Protein Drugs Market Analysis
-
8.1 Europe Recombinant Protein Drugs Market, by Type
-
8.2 Europe Recombinant Protein Drugs Market, by Application
-
8.3 Europe Recombinant Protein Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Recombinant Protein Drugs Market Analysis
-
9.1 APAC Recombinant Protein Drugs Market, by Type
-
9.2 APAC Recombinant Protein Drugs Market, by Application
-
9.3 APAC Recombinant Protein Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Recombinant Protein Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Recombinant Protein Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Recombinant Protein Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Recombinant Protein Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Recombinant Protein Drugs Company Profiles
-
11.1 Novo Nordisk
-
11.1.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novo Nordisk Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.1.3 Novo Nordisk Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Amgen
-
11.2.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Amgen Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.2.3 Amgen Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Sanofi
-
11.3.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Sanofi Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.3.3 Sanofi Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Eli Lilly
-
11.4.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Eli Lilly Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.4.3 Eli Lilly Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Merck Serono
-
11.5.1 Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Merck Serono Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.5.3 Merck Serono Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Ortho Biotech
-
11.6.1 Ortho Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Ortho Biotech Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.6.3 Ortho Biotech Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Roche
-
11.7.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Roche Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.7.3 Roche Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Kyowa Hakko Kirin
-
11.8.1 Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Kyowa Hakko Kirin Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Pharmingen
-
11.9.1 Pharmingen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Pharmingen Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.9.3 Pharmingen Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Abcam
-
11.10.1 Abcam Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Abcam Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.10.3 Abcam Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 GenSci
-
11.11.1 GenSci Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 GenSci Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.11.3 GenSci Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 SL PHARM
-
11.12.1 SL PHARM Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 SL PHARM Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.12.3 SL PHARM Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Dongbao Pharm
-
11.13.1 Dongbao Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Dongbao Pharm Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.13.3 Dongbao Pharm Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Ankebio
-
11.14.1 Ankebio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Ankebio Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.14.3 Ankebio Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 NCPC
-
11.15.1 NCPC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 NCPC Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.15.3 NCPC Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Heng Rui
-
11.16.1 Heng Rui Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Heng Rui Recombinant Protein Drugs Product Profiles, Application and Specification
-
11.16.3 Heng Rui Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Recombinant Protein Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Recombinant Protein Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Recombinant Protein Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Recombinant Protein Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Recombinant Protein Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Recombinant Protein Drugs Market Size and Growth Rate of Recombinant DNA (2017-2028)
-
Figure Global Recombinant Protein Drugs Market Size and Growth Rate of Recombinant RNA (2017-2028)
-
Figure Global Recombinant Protein Drugs Market Size and Growth Rate of Pharmaceutical Industry (2017-2028)
-
Figure Global Recombinant Protein Drugs Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Protein Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Recombinant Protein Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Recombinant Protein Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Recombinant Protein Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Recombinant Protein Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Recombinant Protein Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Recombinant Protein Drugs Market Share, by Manufacturer in 2022
-
Table Global Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Value, by Type (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Recombinant Protein Drugs Price Trend, by Type (2017-2028)
-
Table China Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table China Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Recombinant Protein Drugs Sales Value, by Type (2017-2028)
-
Table China Recombinant Protein Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Recombinant Protein Drugs Price Trend, by Type (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Value, by Application (2017-2028)
-
Table Global Recombinant Protein Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Recombinant Protein Drugs Sales Value Share, by Application (2017-2028)
-
Table China Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table China Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Recombinant Protein Drugs Sales Value, by Application (2017-2028)
-
Table China Recombinant Protein Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Recombinant Protein Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table North America Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table North America Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Recombinant Protein Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Recombinant Protein Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Recombinant Protein Drugs Sales Value and Growth Rate (2017-2028)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Serono Product Profiles, Application and Specification
-
Table Merck Serono Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ortho Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ortho Biotech Product Profiles, Application and Specification
-
Table Ortho Biotech Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kyowa Hakko Kirin Product Profiles, Application and Specification
-
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pharmingen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pharmingen Product Profiles, Application and Specification
-
Table Pharmingen Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abcam Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abcam Product Profiles, Application and Specification
-
Table Abcam Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GenSci Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GenSci Product Profiles, Application and Specification
-
Table GenSci Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SL PHARM Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SL PHARM Product Profiles, Application and Specification
-
Table SL PHARM Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dongbao Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dongbao Pharm Product Profiles, Application and Specification
-
Table Dongbao Pharm Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ankebio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ankebio Product Profiles, Application and Specification
-
Table Ankebio Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NCPC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NCPC Product Profiles, Application and Specification
-
Table NCPC Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Heng Rui Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Heng Rui Product Profiles, Application and Specification
-
Table Heng Rui Recombinant Protein Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
